Linden Capital snaps up Arsenal's BioIVT

The Chicago firm adds to an already busy year of healthcare dealmaking with an $800m-plus deal for the global provider of biological specimens and value-added services.

24 August 2021•3 mins read
Aurora Diagnostics, Summit Partners, KRG Capital, private equity, merger, M&A
LinkedInXEmail
LinkedInXEmail

Related articles